GILD Advances as Price Approaches 52 Week High

$Gilead Sciences(GILD)$

GILD Surged +3.01%: Biotech Giant Rebounds to $125, Eyes 52-Week High

Latest Close Data

Closed at $124.91 on 2026-01-19, up +3.01% ($3.65). The price is now just $3.79 (-2.94%) from its 52-week high of $128.70.

Core Market Drivers

The strong rebound follows a period of net capital outflow over the past five trading days, indicating potential profit-taking subsided and renewed buying interest.

As a leading biopharma firm, Gilead's robust HIV and oncology portfolios continue to provide stable cash flow, supporting its attractive 2.51% dividend yield.

Technical Analysis

Volume ratio of 1.71 confirms above-average participation in the rally.
The latest MACD reading shows a bullish crossover with DIF at 0.05 turning positive above DEA at -0.10, generating a positive MACD histogram of 0.31.
RSI(6) at 60.06 has moved out of neutral territory, indicating strengthening short-term momentum without being overbought.

Key Price Levels

Primary Support: $121.35 (Recent swing low from 2026-01-16).
Strong Resistance: $128.70 (52-Week High). A break above could trigger a new uptrend.
Immediate Pivot: $124.95 (Previous resistance from 2026-01-16). Closing above this level is a positive short-term signal.

Valuation Perspective

Forward P/E of 14.26 is slightly below its historical average of 14.43 and significantly below the +1 Std. Dev of 17.96, suggesting the stock is not overvalued relative to its own history.

Analyst Targets

27 analysts cover GILD with a consensus average price target of $134.45, implying ~7.6% upside from current levels. Sentiment is bullish with 8 Strong Buy, 17 Buy, and 6 Hold ratings.

Weekly Outlook

Expect consolidation near the $125 pivot with a bullish bias. A sustained break above $125 could test the $128.7 resistance. On the downside, a drop below $121.35 support may lead to a retest of the $118-$120 zone.

Risk Disclaimer

This content is for informational purposes only and not financial advice. Past performance does not guarantee future results. Investing involves risks, including the potential loss of principal. Conduct your own research before making any investment decisions.

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now

Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Click to access the activity

Other helpful links:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

To The Moon